Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Medtronic Plc. News

    79,25 $ 0,00% +0,00 $
    In : 73,917 € | 01:00:00 Uhr NYSE aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A14M2J
    ISIN: IE00BTN1Y115
    US-Symbol: MDT
    Typ: Aktie
    Werbung

    Attraktive Knock-Outs auf Medtronic Plc.

    Typ Hebel Bid / Ask WKN Typ Hebel Bid / Ask WKN
    Call
    		4,9 1,51 € / 1,52 €
    SQ0YFX
    Put
    		4,4 1,69 € / 1,70 €
    SN2N7B
    Call
    		7,7 0,96 € / 0,97 €
    SN1TX7
    Put
    		9,6 0,76 € / 0,77 €
    SW5SGG
    Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
    Alle Knock-Outs auf Medtronic Plc.
    Werbung
    Weiter aufwärts?
    Long Hebel 5,94
    UL97Y9

    Unternehmensmeldungen

    25.08.20 - GlobeNewswire
    Medtronic Reports First Quarter Financial Results
    Q1 Revenue of $6.5 Billion Decreased 13% Reported and Approximately 17% Organic Q1 GAAP Diluted EPS of $0.36; Q1 Non-GAAP Diluted EPS of $0.62 DUBLIN, Aug. 25, 2020 ...
    24.08.20 - GlobeNewswire
    Medtronic Board Appoints Kevin Lofton as a New Director
    DUBLIN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that its Board of Directors appointed Kevin Lofton to the Board as an independent ...
    24.08.20 - GlobeNewswire
    Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2021
    DUBLIN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) on Friday, August 21, 2020, approved the fiscal year 2021 second quarter cash ...
    11.08.20 - GlobeNewswire
    Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2021
    DUBLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2021 on Tuesday, ...
    15.07.20 - GlobeNewswire
    Medtronic to Acquire Medicrea
    Medtronic Will Become the First Company to Offer an Integrated Solution Including Artificial Intelligence-​Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted ...
    25.06.20 - GlobeNewswire
    New Real-World Data from Medtronic Global SYMPLICITY Registry Show Renal Denervation Lowered Blood Pressure in Patients with Hypertension Out to Three Years
    Regardless of the Number of Anti-​Hypertensive Medications Prescribed, Majority of Patients with Highest BP Showed Significant Drops at Three Years
    25.06.20 - GlobeNewswire
    FDA Approves First-Of-Its-Kind Percept™ PC Neurostimulator with BrainSense™ Technology
    Next-​Generation Technology Makes Percept™ the First and Only DBS System with Ability to Capture Patient-​Specific Brain Signals  for More Personalized, Data-​Driven Treatment
    22.06.20 - GlobeNewswire
    Medtronic Evolut TAVI System Receives Expanded Indication in Europe to Treat Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality
    The Evolut TAVI Platform Receives New Indication for Patients with Bicuspid Aortic Valves at Extreme, High or Intermediate Risk of Surgical Mortality
    18.06.20 - GlobeNewswire
    Medtronic and Foxconn Partner to Increase Ventilator Production
    Companies Aim to Produce 10,000 Puritan Bennett™ 560 Ventilators Together in the United States Over the Next Year Partnership Established after Medtronic Announces Ventilator ...
    16.06.20 - GlobeNewswire
    ABRE Study Meets Primary Safety and Effectiveness Endpoints
    Medtronic Self-​Expanding Venous Stent Demonstrates Favorable Outcomes in Patients with Venous Outflow Obstruction
    15.06.20 - GlobeNewswire
    Medtronic Micra™ AV Receives CE Mark
    World’s Smallest Pacemaker Can Now Treat Patients with AV Block, Allowing More Potential Candidates for Leadless Pacing
    13.06.20 - GlobeNewswire
    Medtronic Shares Study Results on First of Its Kind Extended Wear Infusion Set from American Diabetes Association Conference
    DUBLIN, June 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced data on its extended wear infusion set ...
    12.06.20 - GlobeNewswire
    Medtronic Presents U.S. Pivotal Trial Data for MiniMed™ 780G Advanced Hybrid Closed Loop System with Automated Correction Bolus Feature
    Data from Two Key Clinical Trials of the Next-​Generation Medtronic Automated Insulin Pump Demonstrates Positive Results for Patients with Type 1 Diabetes
    11.06.20 - GlobeNewswire
    Medtronic Secures CE Mark for MiniMed™ 780G Advanced Hybrid Closed Loop System Designed to Further Simplify Type 1 Diabetes Management
    Next Generation Closed Loop Insulin Pump System Features  Auto-​Correction Algorithm and Bluetooth Connectivity
    05.06.20 - GlobeNewswire
    Medtronic Resolute Onyx™ DES Receives First and Only One-Month DAPT Indication for High Bleeding Risk Patients in Europe
    DUBLIN, June 05, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE ( Conformité Européenne ) ...
    03.06.20 - GlobeNewswire
    Medtronic CEO Geoff Martha to Speak at Goldman Sachs Global Healthcare Conference
    DUBLIN, June 03, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs ...
    22.05.20 - GlobeNewswire
    Medtronic CEO Geoff Martha to Speak at Bernstein Strategic Decisions Conference
    DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Bernstein 36th ...
    21.05.20 - GlobeNewswire
    Medtronic Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Announces Dividend Increase
    Q4 Revenue of $6.0 Billion Decreased 26% Reported and 25% Organic Q4 GAAP Diluted EPS of $0.48; Q4 Non-GAAP Diluted EPS of $0.58 Financial Results In-Line with Update ...
    18.05.20 - GlobeNewswire
    Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses
    DUBLIN, May 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced Jeffrey J. Popma, M.D., professor of medicine ...
    15.05.20 - GlobeNewswire
    Medtronic Congenital Heart Disease Studies Show Strong 10-Year Performance for Melody Transcatheter Pulmonary Valve and Primary Results from the Harmony Pivotal Trial
    Milestone Results Presented as Late-​Breaking Clinical Science at SCAI 2020

    Newssuche

    Videos

    newspaper
    25.04.24 +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »